跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,916 条关于
“NLRP3 inhibitors”
全部
13,916
临床试验
6,428
药物
3,239
机构
9
资讯
4,240
去年
NLRP3 Inhibitors Show Promise Across Autoimmune, Neurodegenerative, and Metabolic Diseases
5年前
Novel NLRP3 Inflammasome Inhibitors Show Promise for Treating Multiple Inflammatory Diseases
去年
Error parsing response
7年前
Novartis Receives Patent for Novel NLRP3 Inflammasome Inhibitors with Potential for Multiple Inflammatory Diseases
去年
Advancing NLRP3 Inhibition: Novel Chemotypes Emerge in Clinical Trials
去年
Ventyx Biosciences Advances NLRP3 Inhibitor Portfolio with Phase 2 Trials
9个月前
BioAge Labs Reports Positive Phase 1 Data for Brain-Penetrant NLRP3 Inhibitor BGE-102
3个月前
NodThera's NLRP3 Inhibitor Ruvonoflast Shows Promising Anti-Inflammatory Effects in Cardiovascular Risk Patients
去年
BioAge Labs Shifts Focus to NLRP3 Inhibitor After Azelaprag Trial Discontinued
去年
NLRP3 Inflammasome Inhibition May Prevent Melanoma Hyper-Progression During Immunotherapy
第 1 页,共 424 页
上一页
下一页